West Africa · Nigeria · Distribution intelligence
Pharma Distribution Intelligence — Nigeria
Distrolens maps NAFDAC-licensed pharma distributors across Nigeria — West Africa's largest pharmaceutical market. Brand portfolios, license currency, beneficial ownership signals from the CAC PSC register, and decision-maker contacts.
Market context
Why Nigeria matters
Nigeria is West Africa's largest pharmaceutical market — $1.8B+ and growing 13% annually. 150+ NAFDAC-licensed manufacturing facilities, hundreds of import-licensed wholesalers, anchored in Lagos, Onitsha, and Kano.
Primary regulator: National Agency for Food and Drug Administration and Control (NAFDAC) — www.nafdac.gov.ng
What we map
Public-source signals for Nigeria
- NAFDAC GRP product registrations and manufacturer of record
- CAC PSC beneficial ownership (ground-truth ownership chains)
- Lagos, Onitsha, Kano cluster geographies
- ECOWAS re-export channels (Ghana, Côte d'Ivoire, Benin)
- Federal and state-tier tender awards
- Decision-maker contacts at top distributors
Use cases
How brand owners use Nigeria data
Brand owner entering Nigeria via licensed channel
We deliver a shortlist of NAFDAC import-licensed wholesalers whose portfolio fits your therapeutic class — with CAC PSC beneficial-ownership context to spot which entities are single-shareholder vs institutional.
Anti-counterfeit / parallel-trade scan
Authorized distributor mapping vs grey-market signals. Identify which channels carry your brand legitimately and which clusters surface anomalies.
Federal + state procurement intelligence
FMOH, FCDA, and high-volume state-level tender award patterns. Spot which distributors hold public-sector relationships in your therapeutic area.
Founder-led · Brief-form intake
Request a Nigeria brief
Send your therapeutic class, target launch window, and any constraints. We respond within 1 business day with scope, evidence sample, and timeline.
Start brief →